115 related articles for article (PubMed ID: 18752124)
21. Cyclin D1 Loss Distinguishes Prostatic Small-Cell Carcinoma from Most Prostatic Adenocarcinomas.
Tsai H; Morais CL; Alshalalfa M; Tan HL; Haddad Z; Hicks J; Gupta N; Epstein JI; Netto GJ; Isaacs WB; Luo J; Mehra R; Vessella RL; Karnes RJ; Schaeffer EM; Davicioni E; De Marzo AM; Lotan TL
Clin Cancer Res; 2015 Dec; 21(24):5619-29. PubMed ID: 26246306
[TBL] [Abstract][Full Text] [Related]
22. Intestinal-type cervical adenocarcinoma in situ and adenocarcinoma exhibit a partial enteric immunophenotype with consistent expression of CDX2.
McCluggage WG; Shah R; Connolly LE; McBride HA
Int J Gynecol Pathol; 2008 Jan; 27(1):92-100. PubMed ID: 18156982
[TBL] [Abstract][Full Text] [Related]
23. Clinical and prognosis value of the CIMP status combined with MLH1 or p16
Saadallah-Kallel A; Abdelmaksoud-Dammak R; Triki M; Charfi S; Khabir A; Sallemi-Boudawara T; Mokdad-Gargouri R
Med Oncol; 2017 Aug; 34(8):147. PubMed ID: 28730335
[TBL] [Abstract][Full Text] [Related]
24. PTEN expression and mutation in colorectal carcinomas.
Li XH; Zheng HC; Takahashi H; Masuda S; Yang XH; Takano Y
Oncol Rep; 2009 Oct; 22(4):757-64. PubMed ID: 19724853
[TBL] [Abstract][Full Text] [Related]
25. Dukes B colorectal cancer: distinct genetic categories and clinical outcome based on proximal or distal tumor location.
Gervaz P; Bouzourene H; Cerottini JP; Chaubert P; Benhattar J; Secic M; Wexner S; Givel JC; Belin B
Dis Colon Rectum; 2001 Mar; 44(3):364-72; discussion 372-3. PubMed ID: 11289282
[TBL] [Abstract][Full Text] [Related]
26. Expression of survivin and cortactin in colorectal adenocarcinoma: association with clinicopathological parameters.
Lee YY; Yu CP; Lin CK; Nieh S; Hsu KF; Chiang H; Jin JS
Dis Markers; 2009; 26(1):9-18. PubMed ID: 19242064
[TBL] [Abstract][Full Text] [Related]
27. Discordance between EGFR expression and clinicopathologic parameters of colorectal adenocarcinoma in Taiwan.
Tsai WC; Lin CK; Lee HS; Chen A; Nieh S; Yu CP; Wu CC; Jao SW; Jin JS
Chin J Physiol; 2012 Oct; 55(5):352-60. PubMed ID: 23282210
[TBL] [Abstract][Full Text] [Related]
28. Clinical outcome and expression of mutant P53, P16, and Smad4 in lung adenocarcinoma: a prospective study.
Bian C; Li Z; Xu Y; Wang J; Xu L; Shen H
World J Surg Oncol; 2015 Mar; 13():128. PubMed ID: 25890228
[TBL] [Abstract][Full Text] [Related]
29. Expression of p-STAT3 in human colorectal adenocarcinoma and adenoma; correlation with clinicopathological factors.
Kusaba T; Nakayama T; Yamazumi K; Yakata Y; Yoshizaki A; Nagayasu T; Sekine I
J Clin Pathol; 2005 Aug; 58(8):833-8. PubMed ID: 16049285
[TBL] [Abstract][Full Text] [Related]
30. Age-related alteration in the association of microsatellite instability with absent hMLH1 expression and histological types of colorectal carcinoma.
Arai T; Sugai T; Kasahara I; Sawabe M; Honma N; Aida J; Nakamura S; Takubo K
Pathol Int; 2006 Oct; 56(10):597-603. PubMed ID: 16984616
[TBL] [Abstract][Full Text] [Related]
31. Colorectal cancers with both p16 and p14 methylation show invasive characteristics.
Hibi K; Nakayama H; Koike M; Kasai Y; Ito K; Akiyama S; Nakao A
Jpn J Cancer Res; 2002 Aug; 93(8):883-7. PubMed ID: 12716465
[TBL] [Abstract][Full Text] [Related]
32. [Clinicopathological significance of expressions of DNA dependent protein kinase catalytic subunit and P16 in colorectal carcinoma].
Lü Y; Zhang HL; Li YZ; Zhao P
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(29):2025-9. PubMed ID: 19080428
[TBL] [Abstract][Full Text] [Related]
33. The invasion front of human colorectal adenocarcinomas shows co-localization of nuclear beta-catenin, cyclin D1, and p16INK4A and is a region of low proliferation.
Jung A; Schrauder M; Oswald U; Knoll C; Sellberg P; Palmqvist R; Niedobitek G; Brabletz T; Kirchner T
Am J Pathol; 2001 Nov; 159(5):1613-7. PubMed ID: 11696421
[TBL] [Abstract][Full Text] [Related]
34. Expression of GAEC1 mRNA and protein and its association with clinical and pathological parameters of patients with colorectal adenocarcinoma.
Wahab R; Gopalan V; Islam F; Mamoori A; Lee KT; Lu CT; Lam AK
Exp Mol Pathol; 2018 Feb; 104(1):71-75. PubMed ID: 29337242
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical expression of p16, p53, and p63 in colorectal adenomas and adenocarcinomas.
Carneiro FP; Ramalho LN; Britto-Garcia S; Ribeiro-Silva A; Zucoloto S
Dis Colon Rectum; 2006 May; 49(5):588-94. PubMed ID: 16575619
[TBL] [Abstract][Full Text] [Related]
36. Expression of phospho-mTOR kinase is abundant in colorectal cancer and associated with left-sided tumor localization.
Melling N; Simon R; Izbicki JR; Terracciano LM; Bokemeyer C; Sauter G; Marx AH
Int J Clin Exp Pathol; 2015; 8(6):7009-15. PubMed ID: 26261591
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathologic features of synchronous colorectal carcinoma: A distinct subset arising from multiple sessile serrated adenomas and associated with high levels of microsatellite instability and favorable prognosis.
Hu H; Chang DT; Nikiforova MN; Kuan SF; Pai RK
Am J Surg Pathol; 2013 Nov; 37(11):1660-70. PubMed ID: 23887157
[TBL] [Abstract][Full Text] [Related]
38. Prognostic importance of COX-2 expression in patients with colorectal cancer.
Yamac D; Celenkoglu G; Coskun U; Akyurek N; Akcali Z; Dursun A; Koybasioglu F
Pathol Res Pract; 2005; 201(7):497-502. PubMed ID: 16164044
[TBL] [Abstract][Full Text] [Related]
39. Clinicopathologic significance of TRAP1 expression in colorectal cancer: a large scale study of human colorectal adenocarcinoma tissues.
Pak MG; Koh HJ; Roh MS
Diagn Pathol; 2017 Jan; 12(1):6. PubMed ID: 28088229
[TBL] [Abstract][Full Text] [Related]
40. Research on expression and importance of p53, p16 and VEGF-C in cervical cancer.
Cai S; Han K
J Gynecol Obstet Biol Reprod (Paris); 2015 Sep; 44(7):639-45. PubMed ID: 25443468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]